344 related articles for article (PubMed ID: 21858154)
1. Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer.
Larriba MJ; Ordóñez-Morán P; Chicote I; Martín-Fernández G; Puig I; Muñoz A; Pálmer HG
PLoS One; 2011; 6(8):e23524. PubMed ID: 21858154
[TBL] [Abstract][Full Text] [Related]
2. The effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles.
DeWitt M; Johnson RL; Snyder P; Fleet JC
J Steroid Biochem Mol Biol; 2015 Apr; 148():103-10. PubMed ID: 25597951
[TBL] [Abstract][Full Text] [Related]
3. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth.
Zheng W; Wong KE; Zhang Z; Dougherty U; Mustafi R; Kong J; Deb DK; Zheng H; Bissonnette M; Li YC
Int J Cancer; 2012 Jan; 130(1):10-9. PubMed ID: 21328347
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cells.
Larriba MJ; Valle N; Pálmer HG; Ordóñez-Morán P; Alvarez-Díaz S; Becker KF; Gamallo C; de Herreros AG; González-Sancho JM; Muñoz A
Endocr Relat Cancer; 2007 Mar; 14(1):141-51. PubMed ID: 17395983
[TBL] [Abstract][Full Text] [Related]
6. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells.
Gröschel C; Aggarwal A; Tennakoon S; Höbaus J; Prinz-Wohlgenannt M; Marian B; Heffeter P; Berger W; Kállay E
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):224-30. PubMed ID: 25777538
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development.
Shelton DN; Sandoval IT; Eisinger A; Chidester S; Ratnayake A; Ireland CM; Jones DA
Cancer Res; 2006 Aug; 66(15):7571-7. PubMed ID: 16885356
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
13. RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells.
Ordóñez-Morán P; Larriba MJ; Pálmer HG; Valero RA; Barbáchano A; Duñach M; de Herreros AG; Villalobos C; Berciano MT; Lafarga M; Muñoz A
J Cell Biol; 2008 Nov; 183(4):697-710. PubMed ID: 19015318
[TBL] [Abstract][Full Text] [Related]
14. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase A antagonist inhibits β-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice.
Brudvik KW; Paulsen JE; Aandahl EM; Roald B; Taskén K
Mol Cancer; 2011 Dec; 10():149. PubMed ID: 22168384
[TBL] [Abstract][Full Text] [Related]
17. Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.
Giardina C; Nakanishi M; Khan A; Kuratnik A; Xu W; Brenner B; Rosenberg DW
Cancer Prev Res (Phila); 2015 May; 8(5):387-99. PubMed ID: 25873367
[TBL] [Abstract][Full Text] [Related]
18. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.
Beildeck ME; Islam M; Shah S; Welsh J; Byers SW
PLoS One; 2009 Nov; 4(11):e7872. PubMed ID: 19924301
[TBL] [Abstract][Full Text] [Related]
19. Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.
Guo H; Nagy T; Pierce M
J Biol Chem; 2014 Nov; 289(45):31534-49. PubMed ID: 25274627
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
